17 PRIMECAP Management BridgeBio Pharma Trades
PRIMECAP Management's position in BridgeBio Pharma is currently worth $31.2 Million. That's 0.03% of their equity portfolio (201st largest holding). The first BridgeBio Pharma trade was made in Q1 2021. Since then PRIMECAP Management bought shares seven more times and sold shares on nine occasions. The investor's estimated purchase price is $41 Million, resulting in a loss of 24%.
News about BridgeBio Pharma Inc and PRIMECAP Management
26,903 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Acquired by New York Life Investment Management LLC
New York Life Investment Management LLC acquired a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the first quarter, according to the ...
Millennium Management LLC Has $8.60 Million Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Millennium Management LLC boosted its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) by 237.0% in the second quarter, according to its most recen...